Replimune Stock Forward View - Double Exponential Smoothing

REPL Stock  USD 3.44  0.57  19.86%   
Replimune Group's Double Exponential Smoothing forecast is generated from the selected price series and evaluated against observed values. Forecast accuracy depends on how stable the recent price trend has been — trending markets suit some models better than others. The Double Exponential Smoothing model projects Replimune at 3.46 for the next trading day, above the most recent closing price. All values shown are model-generated projections and should be evaluated alongside other analytical inputs.
Double exponential smoothing (Holt method) for Replimune extends simple exponential smoothing by adding a trend component. This allows the model to track directional price movement rather than lagging behind a trending series.

Double Exponential Smoothing Price Forecast For the 8th of May

Over a 90-day horizon, the Double Exponential Smoothing model forecasts Replimune at 3.46 for the next trading day, with a mean absolute deviation of 0.37 , mean absolute percentage error of 0.09 , and sum of absolute errors of 22.28 .
This indicates moderate forecast accuracy — the model captures the general trend but not all short-term variation in Replimune's price. This output is intended for short-term analytical reference.

Stock Forecast Pattern

Backtest Replimune  Replimune Price Prediction  Research Analysis  

Forecasted Value

This forecast for Replimune frames the expected trading range using downside and upside bounds rather than a single point target. The current forecast range spans downside near 0.03 and upside near 15.81. The wide range indicates elevated uncertainty in short-term projections.
Market Value
3.44
3.46
Expected Value
15.81

Model Predictive Factors

The table below summarizes the Double Exponential Smoothing model's error metrics for Replimune stock. Lower MAD and MAPE values indicate tighter forecast accuracy. AIC measures relative model quality — lower values indicate less information loss and a better-fitting model. A large Bias suggests systematic over- or under-prediction.
AICAkaike Information CriteriaHuge
BiasArithmetic mean of the errors 0.0927
MADMean absolute deviation0.3713
MAPEMean absolute percentage error0.0944
SAESum of the absolute errors22.28
The model estimates both the level and slope of Replimune Group prices, giving exponentially decreasing weight to older observations. It is best suited for Replimune price data that exhibits a persistent upward or downward trend. A wide divergence between the forecast and actual values may indicate a trend reversal or regime change.

Other Forecasting Options for Replimune

Bollinger Bands applied to Replimune Stock price data measure how far Replimune has deviated from its recent average relative to its own volatility. This distinction drives the choice of forecasting model applied to Replimune's price data.

Replimune Related Equities

These firms work in a similar space as Replimune within the Health Care space and serve as useful points for comparison. Revenue and margin checks across this group help investors set expectations for Replimune's results.
 Risk & Return  Correlation

Replimune Market Strength Events

Market strength indicators for Replimune quantify how the stock responds to shifts in volume and sentiment. These indicators capture shifts in momentum that may precede significant price moves in Replimune.

Replimune Risk Indicators

Analyzing Replimune's risk indicators separates symmetric price swings from asymmetric downside exposure. Understanding and quantifying the risks present in Replimune helps place recent price behavior in context.
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.

Replimune Short Properties

Short-interest data for Replimune reveals whether bearish conviction in the market is gaining traction. Comparing short sentiment with trend behavior, volume, and the broader market narrative provides a more grounded view.
Common Stock Shares Outstanding80.56 million
Cash And Short Term Investments483.8 million

More Resources for Replimune Stock Analysis

A baseline understanding of Replimune Group is formed through its financial statements and trends. The data reflects Replimune's reported financial activity across periods.